AI generated
May 5, 2026, 08:20
Diana Domenica Bruno: New Perinatal Research on Sepsis as Redefining Maternal Risk
Diana Domenica Bruno, Chief Executive Officer at Una Vita, shared a post on LinkedIn:
“New Perinatal Research: Sepsis is Redefining Maternal Risk
Recent 2025–2026 findings are reshaping clinical priorities:
- Maternal sepsis is rising as a leading cause of morbidity and mortality. Delayed recognition – often masked by normal physiologic changes of pregnancy – remains the most preventable failure point.
- Placental pathology is central to infection‑related outcomes. New evidence links subclinical placental inflammation and vascular malperfusion with fetal compromise, stillbirth, and early‑onset neonatal sepsis.
- Early detection protocols are tightening. Updated research supports infection‑specific vital‑sign thresholds, rapid escalation pathways, and earlier initiation of broad‑spectrum coverage when sepsis is suspected.
- Neonatal sepsis trends demand closer surveillance. Rising early‑onset sepsis in preterm infants is strongly associated with maternal infection, prolonged rupture of membranes, and gaps in intrapartum prophylaxis.
Where data matters:
The Una Vita Perinatal Database provides real‑time visibility into infection patterns, placental findings, escalation timelines, and neonatal outcomes – giving leaders the actionable insight needed to strengthen sepsis pathways across the perinatal continuum.
Bottom Line:
Earlier infection recognition, faster escalation, and data‑driven sepsis surveillance are now essential to improving maternal and neonatal outcomes.”

Stay updated with Hemostasis Today.
-
Nov 9, 2026, 22:47Avirup Guha: Early Immune Responses to Androgen Deprivation Therapy and Coronary Plaque Progression
-
Nov 9, 2026, 22:42Angela Forsyth: Joining Novo Nordisk as Medical Liaison for the Ohio Valley Region
-
Nov 9, 2026, 22:36Vladimir Otasevic: Presenting Thromboprophylaxis and Treatment of VTE in Patients With Malignancy
-
Nov 9, 2026, 22:28Dragoș Claudiu Popescu: Corticosteroid Exposure and Thrombotic Risk in ITP
-
Nov 9, 2026, 22:20Cedric Ghevaert: How RNA Processing Defects Affect Megakaryocytes in TAR Syndrome
-
Nov 9, 2026, 22:07Todd C. Villines: PARAMOUNT Shows Benefits of Coronary Plaque-Based Care in Stable Symptomatic Patients
-
Nov 9, 2026, 22:06Maxima Mendez: Complete Results of the Pelacarsen Cardiovascular Outcomes Study at AHA 2026
-
Nov 9, 2026, 22:04The Role of the Spleen in Inflammation During Acute Plasmodium Vivax Malaria – American Journal of Hematology
-
Nov 9, 2026, 21:52Behnood Bikdeli: Honored to Share the Stage at AHA 2026 to Discuss Grant Funding